Accéder au contenu
MilliporeSigma

Czech mass methanol outbreak 2012: epidemiology, challenges and clinical features.

Clinical toxicology (Philadelphia, Pa.) (2014-10-28)
Sergey Zakharov, Daniela Pelclova, Pavel Urban, Tomas Navratil, Pavel Diblik, Pavel Kuthan, Jaroslav A Hubacek, Michal Miovsky, Jiri Klempir, Manuela Vaneckova, Zdenek Seidl, Alexander Pilin, Zdenka Fenclova, Vit Petrik, Katerina Kotikova, Olga Nurieva, Petr Ridzon, Jan Rulisek, Martin Komarc, Knut Erik Hovda
RÉSUMÉ

Methanol poisonings occur frequently globally, but reports of larger outbreaks where complete clinical and laboratory data are reported remain scarce. The objective of the present study was to report the data from the mass methanol poisoning in the Czech Republic in 2012 addressing the general epidemiology, treatment, and outcomes, and to present a protocol for the use of fomepizole ensuring that the antidote was provided to the most severely poisoned patients in the critical phase. A combined prospective and retrospective case series study of 121 patients with confirmed methanol poisoning. From a total of 121 intoxicated subjects, 20 died outside the hospital and 101 were hospitalized. Among them, 60 survived without, and 20 with visual/CNS sequelae, whereas 21 patients died. The total and hospital mortality rates were 34% and 21%, respectively. Multivariate regression analysis found pH < 7.0 (OR 0.04 (0.01-0.16), p < 0.001), negative serum ethanol (OR 0.08 (0.02-0.37), p < 0.001), and coma on admission (OR 29.4 (10.2-84.6), p < 0.001) to be the only independent parameters predicting death. Continuous hemodialysis was used more often than intermittent hemodialysis, but there was no significant difference in mortality rate between the two [29% (n = 45) vs 17% (n = 30), p = 0.23]. Due to limited stockpiles of fomepizole, ethanol was administered more often; no difference in mortality rate was found between the two [16% (n = 70) vs. 24% (n = 21), p = 0.39]. The effect of folate administration both on the mortality rate and on the probability of visual sequelae was not significant (both p > 0.05). Severity of metabolic acidosis, state of consciousness, and serum ethanol on admission were the only significant parameters associated with mortality. The type of dialysis or antidote did not appear to affect mortality. Recommendations that were issued for hospital triage of fomepizole administration allowed conservation of valuable antidote in this massive poisoning outbreak for those patients most in need.

MATÉRIAUX
Numéro du produit
Marque
Description du produit

Sigma-Aldrich
Méthanol, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Méthanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Méthanol, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Méthanol, HPLC Plus, ≥99.9%
Sigma-Aldrich
Méthanol, anhydrous, 99.8%
Sigma-Aldrich
Méthanol, Laboratory Reagent, ≥99.6%
Sigma-Aldrich
Méthanol, suitable for HPLC, gradient grade, suitable as ACS-grade LC reagent, ≥99.9%
Sigma-Aldrich
Méthanol, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8% (GC)
Sigma-Aldrich
Éthanol, ACS reagent, prima fine spirit, without additive, F15 o1
Sigma-Aldrich
Formiate de sodium, ACS reagent, ≥99.0%
Sigma-Aldrich
Méthanol, ACS spectrophotometric grade, ≥99.9%
Sigma-Aldrich
Méthanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Reagent Alcohol, denatured, suitable for HPLC
Sigma-Aldrich
Reagent Alcohol, reagent grade
Sigma-Aldrich
Méthanol, Absolute - Acetone free
Sigma-Aldrich
β-Nicotinamide-adénine-dinucléotide hydrate, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
USP
Méthanol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Méthanol, BioReagent, ≥99.93%
Supelco
Éthanol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ethyl alcohol, denatured, denatured, reagent grade
Supelco
Méthanol, analytical standard
Sigma-Aldrich
Éthanol, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Supelco
Méthanol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
β-Nicotinamide-adénine-dinucléotide hydrate, ≥95% (HPLC)
Sigma-Aldrich
β-Nicotinamide-adénine-dinucléotide hydrate, ≥99%
Sigma-Aldrich
Méthanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Formiate de sodium, reagent grade, 97%
Sigma-Aldrich
β-Nicotinamide-adénine-dinucléotide hydrate, suitable for cell culture, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
Supelco
Ethanol solution, 50 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
Sigma-Aldrich
β-Nicotinamide-adénine-dinucléotide hydrate, Grade AA-1